input
stringlengths 428
39.1k
| output
stringclasses 2
values |
|---|---|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1cc(N2Cc3ccc(Sc4ccc(F)cc4)nc3C2=O)ccc1OCCN1CCCC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C(N)=O)c4ccc(C(F)(F)F)cc34)C2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N[C@@H](Cn1c(=O)cnc2ccc(F)cc21)C1CCC(NCc2ccc3c(n2)NC(=O)CO3)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(NC1COc2cccc(-c3ccnc(CO)c3)c2C1)c1ccc(OCC(F)(F)F)nc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1cc(Nc2cncc(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C[N+]1CC[N+](CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CN(C)Cc1ccccc1-c1ccc(NC(=O)Nc2cccnc2Oc2ccccc2C(C)(C)C)c(F)c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1cccc(-n2cc3nc(-c4ccccc4C)n(CC4CCCN(C(C)C)C4)c(=O)c3n2)c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(C2CCOCC2)n1C)CC3</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1ccc(OC2CN(C(=O)NC3CCN(Cc4ccn(-c5ccc(C(F)(F)F)cc5)c4)CC3)C2)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=S(=O)(c1ccc(F)cc1)N1CCN(CCc2ccc(F)cc2F)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(C)(O)c1nc2cc(Cl)ccc2n1[C@H]1CC[C@@H](NC[C@H]2Cc3ccc(C#N)cc3C2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CCN(CCC2CCN(C(=O)c3ccccc3F)CC2)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1cc(CN2CCOCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C1NC(=O)/C(=C\c2ccccc2OCc2nnc(-c3ccccc3)o2)S1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>OC(c1ccccc1)(c1ccccc1)C1CCN(CCCOc2ccc(-c3ccccc3)cc2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1cc(O[C@H](CCCCNCc2ccc(F)cc2)C(=O)NO)cc(C)c1F</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2nc3cc(F)ccc3s2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N#CC=C1CCN(c2ccc(N3C[C@H](Cn4cc(F)nn4)OC3=O)cc2F)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>FC(F)(F)c1ccccc1CN(C1CCOCC1)C1CCNC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCN(CC)CCN1CCCc2cc(NC(=N)c3cccs3)ccc21</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CN(CCN1CCN(c2ccc3c(c2)OCO3)C1=O)CC12CCC(CC1)C2(C)C</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C[C@H]1[C@H](/C=C/c2ccc(-c3ccccc3C#N)cn2)[C@@H]2[C@@H](C)OC(=O)[C@]2(C(C)(C)C(N)=O)CC1(F)F</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C[C@@H]1C[C@H](O[C@H](C)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H](c2ccc(F)cc2)CNC1=O</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(C)[C@@H](NC(=O)c1ccccc1)C(=O)N1CCC(c2ccc(Cl)cc2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCOC(=O)C1CCC(N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O[C@H](COc1ccc(F)cc1)CN1CCN(Cc2ccc(Cl)c(Cl)c2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ccc(F)cc1COC1CCc2ccc(N3CCNCC3C)nc21</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CN(c1ccccc1)S(=O)(=O)c1cccc(C(=O)N2CCN(C(=O)Cc3ccc(F)cc3)CC2)c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(CCc1ccccn1)N[C@H]1CC[C@H](c2ccc(O)cc2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1c(C#N)cccc1[C@H]1CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)C[C@H]2CO1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(=O)NC1CCC(C(C)C(N)C(=O)N2CCC(F)C2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Nc1nc2c(C(=O)N[C@@H]3CN4CCC3CC4)cccc2o1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1cc(Cl)nnc1N1CCN(C(=O)Nc2nc3ccc(F)cc3s2)[C@H](C)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1c(F)cccc1Cl</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CNC1CCC(c2c[nH]c3ccc(NC(=N)c4cccs4)cc23)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCCN3CCCC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1cc(-c2cn(C3C[C@@H](C(C)(C)C)CCN(CC45CC6CC(CC(C6)C4)C5)C3=O)nn2)ccc1-n1cnc(C)c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2occc2c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COCCOc1ccc2c(c1)Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ccc2c(-c3nnc(SCCCN4CCc5c(Cl)cc6oc(C)nc6c5CC4)n3C)cccc2n1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C1NCCN1CC[NH+]1CCC(c2cn(C3CCCCC3)c3ccc(Cl)cc23)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1ccc(C2(O)CCC(N3CC(NC(=O)CNc4noc5ccc(C(F)(F)F)cc45)C3)CC2)cn1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CNc1ccc(/C=C/c2c(F)cccc2F)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(C)(O)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)cccc2n1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1ccc2c(-n3cnc(C)c3)nc(C#N)c(-c3cccc(F)c3)c2c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N#Cc1ccc(N2N=C(c3ccc4[nH]c(=O)oc4c3)CC2c2ccc(F)cc2)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=S(=O)(c1ccc(F)cc1)c1ccc(C=Cc2ccc(F)cc2)cn1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N#Cc1ccc(Cn2cncc2C[N+]C2CCN(C(=O)c3cccc(Cl)c3)C2=O)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1nc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)no1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cn[nH]c1C1CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>c1ccc2cc(CO[C@H]3CCNC3)ccc2c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C[C@H]1CN(c2ccc(C(=O)Nc3ccccc3N)cn2)CCN1C(=O)OCc1ccccc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>c1ccc(-c2cnc(Nc3cc(CN4CCCC4)ccn3)s2)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC1Cc2c([nH]c3cc(Cl)ccc23)C2(N1)C(=O)Nc1ccc(Cl)cc12</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=c1cc[nH+]c(NCC2CCN(c3nc4ccccc4n3Cc3ccc(F)cc3)CC2)[nH]1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3cccc(F)c3)cc(-c3ccc4c(c3)OCO4)c2)c1CCC(=O)O</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3c(O)cccc32)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COC1COCCC1NC1CCC(C(=O)N2CCN(c3cc(C(F)(F)F)ncn3)CC2)(C(C)C)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N#Cc1ccc(Cn2cncc2C[NH2+][C@H]2CCN(C(=O)c3cccnc3[O-])C2=O)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC[C@H](C)[C@H](C(=O)O)N1CC(CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccccc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COC(=O)N1CC[C@H](N(Cc2cccc(F)c2F)c2ccc(C#N)c(Cl)c2)C1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCCCCCCN1CCC(C(=O)c2ccc(Cl)cc2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCCN(CC)CC#Cc1ccc(C)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(C)c1noc(N2CCN(c3ncc(OCc4ccc(S(C)(=O)=O)cc4F)cn3)[C@H](C)C2)n1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>N[C@H](C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(NS(=O)(=O)CC(F)(F)F)cc2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C=S(=O)(NC)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C#CC1(O)CCC(N2CC(NC(=O)CNc3nn(C)c4ccc(C(F)(F)F)cc34)C2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C[C@@H](OC1CCC2NC1(c1ccccc1)CC2c1nnn(C)n1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CN(C)CCCn1nc(-c2cnc3[nH]cc(C(=O)NC(C)(C)C)c3n2)c2cc(OC(F)F)ccc21</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4ccnc4)ccc2-3)cs1)COc1ccccc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCn1cc(N2CCN(Cc3nc4c5cccc(OC)c5nc(N)n4n3)[C@H](C)C2)cn1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>CCOC(=O)C1=C(CN2CCOC(CCC(=O)O)C2)NC(c2nccs2)=NC1c1ccc(F)cc1Br</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1cc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(F)cc54)CC3)nc2cc1Cl</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ccc(N2CCN(CCN(C)CC34CCC(CC3)C4(C)C)C2=O)cc1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>c1cn(C2CCCCC2)nc1OCCN1CCOCC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(A)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ncoc1-c1nnc(SCCCN2CCc3cc4nc(C(F)(F)C(F)(F)F)oc4cc3CC2)n1C</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
<|im_start|>user
Instructions: Answer the following question about drug properties.
Context: Human ether-à-go-go related gene (hERG) is crucial for the coordination of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe adverse effects. Therefore, reliable prediction of hERG liability in the early stages of drug design is quite important to reduce the risk of cardiotoxicity-related attritions in the later development stages.
Question: Given a drug SMILES string, predict whether it
(A) does not inhibit hERG (B) inhibits hERG
Drug SMILES: <SMILES>O=C1CCCN1C1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1</SMILES>
Answer:<|im_end|>
<|im_start|>assistant
|
<think>
</think>
(B)<|im_end|>
|
End of preview. Expand
in Data Studio
No dataset card yet
- Downloads last month
- 48